Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInventory AverageInvested Capital

Syndax Pharmaceuticals (SNDX) Return on Assets (2016 - 2021)

Historic Return on Assets for Syndax Pharmaceuticals (SNDX) over the last 6 years, with Q3 2021 value amounting to 0.08%.

  • Syndax Pharmaceuticals' Return on Assets rose 2700.0% to 0.08% in Q3 2021 from the same period last year, while for Sep 2021 it was 0.08%, marking a year-over-year increase of 2700.0%. This contributed to the annual value of 0.48% for FY2024, which is 1000.0% down from last year.
  • Syndax Pharmaceuticals' Return on Assets amounted to 0.08% in Q3 2021, which was up 2700.0% from 0.15% recorded in Q2 2021.
  • In the past 5 years, Syndax Pharmaceuticals' Return on Assets ranged from a high of 0.08% in Q3 2021 and a low of 0.84% during Q4 2018
  • Moreover, its 5-year median value for Return on Assets was 0.46% (2017), whereas its average is 0.51%.
  • Its Return on Assets has fluctuated over the past 5 years, first tumbled by -3800bps in 2018, then skyrocketed by 5200bps in 2020.
  • Syndax Pharmaceuticals' Return on Assets (Quarter) stood at 0.46% in 2017, then tumbled by -82bps to 0.84% in 2018, then grew by 2bps to 0.82% in 2019, then soared by 64bps to 0.3% in 2020, then soared by 73bps to 0.08% in 2021.
  • Its Return on Assets stands at 0.08% for Q3 2021, versus 0.15% for Q2 2021 and 0.19% for Q1 2021.